lobbying_activities: 1226819

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1226819	6d338806-0b06-4f68-89b1-7e1772df3c87	Q1	PURPLE ADVOCACY, LLC	400870549	DAVITA INC.	2012	first_quarter	MMM	End-stage renal disease reimbursement and policies related to Medicare Secondary Payor provisions in the new Healthcare Exchange.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2012-04-13T16:12:39.503000-04:00